Eric Langer

CMOs are becoming sought-after partners as a result of their use of innovative technologies, single-use bioreactors, and other novel bioprocessing services.

There are significant differences between small molecules and biologics fill/finish capacity.

Outsourcing is taking on a greater role in the biopharmaceutical manufacturing industry.

Annual outsourcing study identifies the markets best poised to profit from the internationalization of the outsourcing.

Annual study shows geographic proximity not a factor in CMO selection.

Sponsors are demanding high levels of professionalism, performance, and effectiveness in managerial areas to accompany CMOs?' technical expertise.

Annual study shows CMO technical expertise is not enough.

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

With budgets growing, clients see CMOs' costs as less crucial and consider other factors.

With budgets growing, clients see CMOs' costs as less crucial.

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

In biopharmaceutical manufacturing, outsourcing and off-shoring have migrated into much more high-value areas.

Novel expression systems such as plant-based manufacturing platforms are expected to dramatically lower manufacturing costs. How will the market respond with outsourcing options?

CMOs may find opportunities in alternative expression services.

A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.

Interest in chromatography innovation continues to decline.

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

A CMO perspective on the CMO-client partnership.

The industry may not be ready for India and China as regulatory issues emerge.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

The industry may not be ready for India and China as regulatory issues emerge.

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.

A recent study shows growth in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Will international biomanufacturing outsourcing become mainstream in this decade?

Innovation resulting in improved productivity continues unabated and is a primary driver for many of the current biopharmaceutical trends.

Will international biomanufacturing outsourcing become mainstream in this decade?